-transparent.png){kind=logo}
Plasma prolactin and fluphenazine concentrations were measured in a group of 17 patients (9 males, 8 females) with schizophrenia who were receiving chronic treatment with fluphenazine decanoate. Neither measure was significantly correlated with clinical effect, as measured by the Brief Psychiatric Rating Scale, at any of the 5 pre-injection times examined. None of the measures showed statistically significant (P greater than 0.05; MANOVA) variations with time. Neither measure showed a significant correlation with the dose (expressed as mg/kg) of fluphenazine. The implications of the study for monitoring chronic treatment of schizophrenia are discussed.
Related Publications
T R Norman, and
P F Marriott, and
N M Kimber, and
G D Burrows
January 1982,
The American journal of psychiatry,
T R Norman, and
P F Marriott, and
N M Kimber, and
G D Burrows
January 2002,
Schizophrenia research,
T R Norman, and
P F Marriott, and
N M Kimber, and
G D Burrows
February 1988,
The Journal of clinical psychiatry,
T R Norman, and
P F Marriott, and
N M Kimber, and
G D Burrows
January 1986,
Psychopharmacology bulletin,
T R Norman, and
P F Marriott, and
N M Kimber, and
G D Burrows
January 1986,
Psychopharmacology,
T R Norman, and
P F Marriott, and
N M Kimber, and
G D Burrows
May 1991,
The British journal of psychiatry : the journal of mental science,
T R Norman, and
P F Marriott, and
N M Kimber, and
G D Burrows
July 1978,
Psychopharmacology bulletin,
T R Norman, and
P F Marriott, and
N M Kimber, and
G D Burrows
January 1981,
Progress in neuro-psychopharmacology,
T R Norman, and
P F Marriott, and
N M Kimber, and
G D Burrows
September 1981,
The American journal of psychiatry,
T R Norman, and
P F Marriott, and
N M Kimber, and
G D Burrows
January 1980,
The American journal of psychiatry,
